Progression-free survival (PFS) of first-line VEGF-targeted therapy as a prognostic parameter for overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 4591-4591 ◽  
Author(s):  
C. Seidel ◽  
M. Fenner ◽  
C. W. Reuter ◽  
A. Ganser ◽  
V. Gruenwald

Cancer ◽  
2010 ◽  
Vol 117 (12) ◽  
pp. 2637-2642 ◽  
Author(s):  
Daniel Y. C. Heng ◽  
Wanling Xie ◽  
Georg A. Bjarnason ◽  
Ulka Vaishampayan ◽  
Min-Han Tan ◽  
...  






Sign in / Sign up

Export Citation Format

Share Document